Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-18

Clinical Trial Update: Late Night Snack and Insulin Glargine [NA]

View source ↗

Summary

This completed clinical trial update examines the relationship between late-night snacking and insulin glargine use in people with Type 1 diabetes, with hypogly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lantus (insulin glargine)

Snippet

Sponsor: Diabeteszentrum Bad Lauterberg im Harz | Conditions: Type 1 Diabetes, Hypoglycemia | NA | Status: COMPLETED